Case series of type III hyperlipoproteinemia in children

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Fung, Michelle ^a   Hill, John ^b   Cook, Donald ^c   Frohlich, Jiri ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c Rockyview General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; ATORVASTATIN; EZETIMIBE; FENOFIBRATE; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; LIPOPROTEIN LIPASE; NICOTINIC ACID; POLICOSANOL; ROSUVASTATIN; SALMON OIL; SIMVASTATIN; THYROTROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHILD; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG DOSE INCREASE; DYSLIPIDEMIA; ENZYME ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 1; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; MALE; METABOLIC SYNDROME X; PANCREATITIS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SPLENECTOMY; SPLENOMEGALY; STABLE ANGINA PECTORIS; XANTHOMA;

EID: 79959306352     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.02.2011.3895     Document Type: Article

References (28)

1. Mahley RW, Huang Y, Rall SC Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res 1999;40:1933-49. (Pubitemid 29523420)
2. Walden CC, Hegele RA. Apolipoprotein E in hyperlipidemia. Ann Intern Med 1994;120:1026-36. (Pubitemid 24169283)
3. Godolphin WJ, Conradi G, Campbell DJ. Type-3 hyperlipoproteinaemia in a child. Lancet 1972;1:209-10.
4. Pimstone SN, Gagné SE, Gagné C, et al. Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995;15:1704-12.
5. Carr MC, Brunzell JD, Deeb SS. Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms. J Lipid Res 2004;45:466-73. (Pubitemid 38337993)
6. Kobayashi J, Yamazaki K, Tashiro J, et al. Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone. Clin Endocrinol (Oxf) 1997;46:627-30. (Pubitemid 27286936)
7. Lindner MA, Illingworth DR. Expression of type III hyperlipoproteinemia in an adolescent patient with hypothyroidism. J Pediatr 1988;113:86-9.
8. Feussner G, Ziegler R. Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype. J Intern Med 1991;230:183-6.
9. Krsek M, Ceska R, Horínek A, et al. Type III hyperlipoproteinaemia and primary amenorrhoea associated with severe hypothyroidism. Acta Paediatr 2000;89:1023-4. (Pubitemid 30643745)
10. Kashyap AS, Sharma HS, Kumar P. Dental anomalies in Williams syndrome. Postgrad Med J 2000;76:712.
11. Crook MA, Mukherjee A, Marshall K. Unusual presentations to a lipid clinic. Postgrad Med J 1999;75:633-4. (Pubitemid 29452603)
12. Kashyap AS, Anand KP. Primary amenorrhoea and xanthomatosis. Lancet 2004;363:616. (Pubitemid 38264180)
13. Stone NJ. Secondary causes of hyperlipidemia. Med Clin North Am 1994;78:117-41. (Pubitemid 24029410)
14. Carmena R, Roy M, Roederer G, et al. Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations. Atherosclerosis 2000;148:113-24.
15. Feussner G, Dobmeyer J, Nissen H, et al. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia. Am J Med Genet 1996;65:149-54.
16. Sakuma N, Iwata S, Ikeuchi R, et al. Coexisting type III hyperlipoproteinemia and familial hypercholesterolemia: a case report. Metab Clin Exp 1995;44:460-5.
17. Hopkins PN, Wu LL, Schumacher MC, et al. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction. Arterioscler Thromb 1991;11:1137-46.
18. Fung M, Bebb R, Frohlich J. Follow-up of type III hyperlipoproteinaemia in a child. Lancet 2001;358:2171. (Pubitemid 34094920)
19. Mann WA, Meyer N, Berg D, et al. Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors. Atherosclerosis 1999;145:61-9. (Pubitemid 29292701)
20. Dobiásová M, Adler L, Ohta T, et al. Effect of labeling of plasma lipoproteins with [(3)H] cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma. J Lipid Res 2000;41:1356-7.
21. Dobiásová M, Frohlich J. Measurement of fractional esterification rate of cholesterol in plasma depleted of apoprotein B containing lipoprotein: methods and normal values. Physiol Res 1996;45:65-73. (Pubitemid 26091968)
22. Kimura W, Mössner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol 1996;20:177-84. (Pubitemid 27044760)
23. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990;19:783-91.
24. Dirisamer A, Hachemian N, Bucek RA, et al. The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr 2003;162:421-5. (Pubitemid 36693745)
25. de Jongh S, Lilien MR, op't Roodt J, et al. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 2002;40:2117-21. (Pubitemid 36005896)
26. de Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 2002;106:2231-7. (Pubitemid 35222218)
27. Vohl MC, Szots F, Lelièvre M, et al. Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia. Atherosclerosis 2002;160:361-8. (Pubitemid 34159329)
28. Lambert M, Lupien PJ, Gagné C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics 1996;97:619-28. (Pubitemid 26138089)